Not Yet Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06867042

Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment

A Double-blind, Randomized, Multicenter, Parallel, Placebo-controlled Clinical Study to Evaluate the Efficacy, Safety and Tolerability of Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment

Sponsor: Jina Pharmaceuticals Inc.

Conditions Ulcerative Colitis (UC) Ulcerative Colitis, Active Moderate

Interventions Identical Tacrolimus-free Lipid Suspension for Enema Tacrolimus Lipid Suspension for enema

Updated 1 time since 2025 Last updated: Mar 10, 2025 Started: Apr 30, 2025 Primary completion: Dec 31, 2025 Completion: Apr 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Ulcerative Colitis (UC) and Ulcerative Colitis, Active Moderate and is currently actively recruiting participants. Jina Pharmaceuticals Inc. leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

1 version recorded

Not Yet Recruiting — PHASE2 [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jina Pharmaceuticals Inc.
Novum Pharmaceutical Research Services

Data source: Jina Pharmaceuticals Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.